This activity is supported by independent educational grants from Incyte Corporation, Sanofi and Regeneron Pharmaceuticals, Novartis Pharmaceuticals Corporation, Pfizer Inc., and Boehringer Ingelheim Pharmaceuticals Inc.
Multiple skin conditions — including psoriasis, atopic dermatitis, and alopecia areata — are mediated by complex immunological pathways that drive disease onset and progression. Recent years have seen the introduction of novel targeted therapies inhibit cytokines that play key roles in these pathways, and many more related therapies are in development. Targeted immune-modulating therapies offer patients with moderate to severe disease additional opportunities to achieve and maintain disease control. However, the rapidly growing therapeutic armamentarium presents challenges for managed care professionals seeking to develop and implement evidence-based, patient-centered policies to ensure that the right patient has access to the right therapy at the right time. During Specialty Connect, experts will focus on managed care considerations for managing immune-mediated skin conditions. Topics will include the future pipeline, considerations for treatment selection, and formulary and financial risk management strategies.
Specialty Connect is a strategic, forward-thinking pre-conference program designed to focus on topics important to those involved with specialty management. The program is designed for and with industry leaders, experts, and managed care professionals operating in this fast-growing sector and will provide opportunities to both learn and network with those interested in specialty management.
At the completion of this activity, participants should be able to:
- Describe impact of moderate-to-severe immune-mediated skin conditions on clinical and patient-reported outcomes, healthcare utilization, and costs.
- Differentiate new and emerging targeted therapies for immune-mediated skin conditions based on mechanisms of action, efficacy and safety data, and indications.
- Discuss guidelines, clinical data, and patient factors to treatment decision-making for diverse patients with immune-mediated skin conditions.
- Identify formulary designs, contracting, and other financial risk management strategies for the treatment of immune-mediated skin conditions.
Casey Butrus, PharmD
Stephanie Cho, PharmD, BCPS
Clinical Pharmacy Specialist in Dermatology
Kaiser Permanente Colorado
Lone Tree, CO
National Psoriasis Foundation
La Mesa, CA
Cheri Frey, MD
Asst Professor, Program Director
Leah M. Howard, JD
President & CEO
National Psoriasis Foundation
Steven S. Kheloussi, PharmD, MBA
Manager, Clinical Pharmacy Strategies
Clive Liu, MD
Eleanor M. Perfetto, PhD, MS
University of Maryland School of Pharmacy
The Academy of Managed Care Pharmacy (AMCP) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
ACPE UAN:0233-0000-22-031-H01-P • Activity Type: Knowledge-Based
Contact Hours: 4
Release Date: October 11, 2022 • Expiration Date: December 31, 2023
Activity Fee: Free for Members and Non-Members
Participants should claim continuing pharmacy education (CPE) credit for this home study activity only if they have not claimed credit for the live activity presented at Nexus 2022. CPE credit will be processed through the AMCP Learn portal and reported directly to CPE Monitor. Please allow 72 hours for processing and posting in your NABP account.
To receive credit for an online activity you must:
- Review the full content of the activity.
- Successfully complete the post-test (required to pass with a score of 70% or higher, it may be taken a maximum of three times).
- Complete a specific activity evaluation.
System Technical Requirements/Viewing Requirements:
System Requirements Courses and learning activities are delivered via your Web browser and Acrobat PDF. For all activities, you should have a basic comfort level using a computer and navigating websites. View the minimum technical and system requirements for continuing education online learning activities.
|Activity Number||Credit Amount||Accreditation Period|
|ACPE UAN #0233-0000-22-031-H01-P||4 Contact Hours||October 11, 2022 - December 31, 2023|